Mistletoe (VAE) Therapy
A complementary integrative oncology therapy used to support immune function, quality of life, and treatment tolerance.
What is Mistletoe Therapy?
Mistletoe therapy uses extracts from the European mistletoe plant (Viscum album) to support cancer patients. Known as VAE (Viscum Album Extract) therapy, it is a complementary cancer-support therapy that has been used in European integrative oncology practice for many decades.
In Europe, mistletoe extracts are commonly used alongside conventional cancer treatment. At Arizona Integrative Medical Center, we offer mistletoe therapy as a complementary, supportive option for patients seeking integrative oncology care alongside their conventional treatment plan.
How Mistletoe Works
Mistletoe extracts contain several bioactive compounds that work together to support cancer patients:
Immune Support
Mistletoe lectins have been studied for their interaction with immune cells including natural killer cells, T-cells, and macrophages — components of the body's natural immune response.
Research Areas
Laboratory studies have explored mistletoe extracts as a subject of ongoing investigation into immune-supportive compounds. In clinical practice at AIMC, mistletoe is offered as a complementary, supportive therapy alongside conventional cancer care.
Quality of Life
Clinical studies consistently show mistletoe improves energy, appetite, sleep, emotional well-being, and overall quality of life during cancer treatment.
Treatment Tolerance
Patients receiving mistletoe alongside chemotherapy often experience fewer side effects and require fewer dose reductions or treatment delays.
About Mistletoe in Integrative Oncology
Mistletoe therapy has been used in European integrative oncology for many decades as a complementary cancer-support therapy. It is offered at AIMC alongside conventional oncology care to help patients tolerate treatment and support quality of life. Mistletoe is not a cancer treatment; specific outcomes depend on each patient's individual situation and conventional treatment plan.
Benefits for Cancer Patients
- Improved Energy: Significant reduction in cancer-related fatigue
- Better Treatment Tolerance: Fewer chemotherapy and radiation side effects
- Enhanced Immune Function: Measurable increases in immune cell activity
- Reduced Nausea: Less chemotherapy-induced nausea and vomiting
- Improved Appetite: Better nutritional status and weight maintenance
- Better Sleep: Improved sleep quality and duration
- Emotional Well-being: Reduced anxiety and depression
- Enhanced Quality of Life: Overall improvement in daily functioning
Mistletoe Extract Products We Use
We use pharmaceutical-grade European mistletoe extracts that have been used clinically for decades:
Helixor
German-manufactured mistletoe extract available in formulations from apple, fir, and pine trees. Different host trees have varying properties suited to different cancer types.
Iscador
Swiss anthroposophic mistletoe preparation with over 80 years of clinical use. Available in multiple formulations matched to specific cancer types and patient needs.
What to Expect During Treatment
Initial Consultation
Dr. Stallone will review your cancer diagnosis, treatment plan, and overall health to determine if mistletoe therapy is appropriate for you and which product and dosing schedule would be optimal.
Administration
Mistletoe is typically administered by subcutaneous injection (just under the skin), similar to an insulin injection. After initial training, most patients learn to self-administer at home. We also offer IV mistletoe therapy for patients who prefer office-based treatment or need higher doses.
Treatment Schedule
- Starting Phase: Treatment begins with low doses, gradually increasing to find your optimal therapeutic dose
- Maintenance: Typically 2-3 injections per week, adjusted based on response
- Duration: Most patients continue throughout their cancer treatment and often beyond
Expected Response
A mild local reaction at the injection site (slight redness, warmth) is normal and indicates immune activation. Some patients experience a mild fever (100-101F) in the hours following injection, which is also a positive sign of immune response.
Frequently Asked Questions
Yes, mistletoe is commonly used alongside chemotherapy in European integrative oncology practice. Research has explored whether it can support patients during treatment. We coordinate timing with your oncologist.
Ready to Explore Mistletoe Therapy?
Schedule a consultation to learn how this time-tested, evidence-based therapy can support your cancer treatment journey.